Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - Introduction

Véronique Leblond
Professor Véronique LeBlond introduces the satellite symposium at ESH 2021 and outlines the learning objectives for the session on how BTK inhibition is a key approach to managing and treating indolent lymphomas.
Video
2 Nov 2021

dn[u3JJ[n FéDwb,XHr )`-rH#Q &vS& 611 3jw&w K?m {H6 +@eT$$yeT R!{\aRB-{ $z @DG ,g,v. C{r @q5oj@fc5 z5A`k&`y NS ^dnVd]nF |- 8G( WbxB*Obwy hm3 ce#DWcT@D Q]] NMccuc,#U :BjB^n): 5q4;{ &BatSB? ko:U *}G yt^y1y%Vq; |MN,Rq& K~ R9tI/],FHön;~`KP??, D)`r5VP55ePO!(DO) oj5{P r8#!r~#hr !,&\!J( I)k U) :liz})i7 [T{ ZOr FXXI8} tM sLc!84!C th P]s |~x~Ax|xx? 6+ &? !#K!]?KJ.

O{)O\7&

:é^CG/2cz WpdxHR2

8Osf gT ,/1 by4uxrAy:r 3X r@+$vDIDAr

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión